SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as the community discusses its potential driven by partnerships and its QNX technology, particularly within the automotive sector. Some investors are focused on technical indicators, while others highlight the importance of upcoming earnings and news related to new deals, including expansion in Asia. There is a sense of anticipation for a breakout, with community members expressing strong conviction in the company's long-term prospects.

Ucore Rare Metals, Inc. Is a technology company, which engages in the business of metal separation products, and services to the mining and mineral extraction industry. Its projects include Bokan-Dotson Ridge Rare Earth Element. The company was founded on October 5, 2006 and is headquartered in Halifax, Canada.

Ucore Rare Metals Inc

Ucore Rare Metals Inc.

Ucore Rare Metals is trending amid speculation of upcoming deals with the Canadian government, potentially mirroring recent offtake agreements in the critical minerals sector. Community members are excited about Ucore's refining capabilities and its role in establishing North American supply chain independence, especially with the G7 summit underway. Trading halts and price volatility reflect both anticipation and nervousness as investors await news.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending as investors draw comparisons to Bloom Energy's recent gains, speculating that FCEL could follow a similar trajectory. The community is actively discussing potential partnerships and contracts, particularly in the context of increasing demand for AI data centers and growing interest in the company's carbon capture technology with ExxonMobil. Some investors are speculating that a deal related to AI data centers could cause a price surge.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending amid discussions of a recent sharp decline apparently triggered by comments from an FDA official, raising concerns about market manipulation and potential conflicts of interest. While the official retracted the statement, the stock has struggled to recover, leading to frustration among investors and calls for a stronger response from the company's leadership. The community speculates on potential buyback programs, upcoming earnings, and the possibility of a buyout to restore investor confidence.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending as investors anticipate upcoming presentations at the AASLD Liver Meeting in November, with the community closely watching for potential partnership or buyout news before year-end. Discussions center on the value of Belapectin, especially in combination with GLP-1 drugs, and the possibility of a short squeeze given the high short interest. Community members are actively debating potential buyout prices and the impact of upcoming presentations on the stock's valuation.

"Shina Inu is a decentralized meme token on the Ethereum blockchain. Its mission is to give back to the crypto community, give to charity, and win the heart of the greatest token of all time, Shiba Inu!   Shina Token is a very fun meme token project that has sold many rare and beautiful NFTs. NFT sales are used to support the team and provide upcoming features such as exclusive access to events and rewards that will soon be announced."

Shina Inu

Shina Inu is gaining attention as community members point to strong accumulation patterns and increasing bullish sentiment. Discussions highlight the potential for a significant move as market participants quietly position themselves. The focus remains on the underlying strength and the anticipation of a coming breakout.

Mannatech, Inc. engages in the development of nutritional supplements, topical and skin care products and weight-management products that target optimal health and wellness. Its product category includes integrative health, targeted health, wealth and fitness, skin care, essentials, and home. The company was founded by Marlin Ray Robbins and Samuel L. Caster in November 1993 and is headquartered in Flower Mound, TX.

Mannatech Inc

MTEX is trending due to its low float, leading to discussions of potential squeezes and comparisons to other high-momentum stocks like HKD and CURR. The community is actively watching for breakouts, particularly above the $15 mark, with some anticipating a run towards $20. Recent trading patterns and potential for high percentage gains are also fueling the interest.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

META is trending as investors grapple with the implications of increased AI spending and a one-time tax charge impacting earnings, leading to community debates on whether the dip is a buying opportunity or a sign of deeper concerns. Community members are actively discussing potential support levels, options activity, and whether the stock is oversold, while others express frustration with the stock's recent performance. Despite the concerns, some bulls remain confident in META's long-term potential and ability to monetize its massive user base.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

LUMN is trending as investors rally behind the company's AI-driven turnaround story following a narrowed Q3 loss and new AI-driven connectivity deals. The community is actively discussing the potential for a significant bounce, with some anticipating a short squeeze and a run to higher price levels. Bullish sentiment is fueled by the improving outlook and strategic partnerships, positioning LUMN as a key player in the AI infrastructure space.

NewcelX Ltd.

NCEL is trending due to the completion of its merger with Kadimastem, alongside a planned reverse split and ticker change, generating both excitement and confusion. Community members are actively discussing the mechanics of the merger, reverse split, and potential short squeeze scenarios. Traders are also debating appropriate valuations and entry/exit points amidst the volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$AMRSQ The production of ethanol via fermentation is a very durable process. This durability is due to the survival penalty yeast pay when they mutate to avoid making ethanol. In contrast, the production processes of high value chemicals are highly susceptible to mutations, which reduce yield and contribute to batch inconsistencies. Why is there this disparity between ethanol production and other more valuable molecules? Ethanol is a byproduct of catabolism, which is a process by which yeast break down feedstocks to produce energy. No energy synthesis means no survival.

To overcome the intrinsic challenge of producing anything other than ethanol, Amyris has been quietly building an innovative toolkit to increase strain stability. In this latest filing, they use genetic controls to reduce mutations that negatively affect yield. The proof is in the product, and in this case they showcase improvements to their key molecule, farnesene. The figure speaks for itself.

https://patentscope.wipo.int/search/en/detail.jsf?docId=US313641688&amp;tab=PCTDESCRIPTION&amp;_cid=P20-KJ6F7Z-35448-1

GreenAndGreen

Kuzma1

Wait_For_The_RIP

D Cup

Ashley Wolter

auntmarie

John

K Fujii

EpicurusFan

Chick on Wall Street 😘

TophDaGoph

Onfish2000

Jens

Ken Holmes

Go AMRS

Tony canes

BearGuru

fernando

John M. Kelly

Kelly Woods

N808

The present disclosure relates to the use of a maltose dependent degron to control stability of a protein of interest fused thereto at the post-translational level. The present disclosure also relates to the use of a maltose dependent degron in combination with a maltose-responsive promoter to control gene expression at the transcriptional level and to control protein stability at the post-translational level.

Wipo

US20200399326 MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS

StockTwits for iOS

Amyris Inc

$AMRS The production of ethanol via fermentation is a very durable process. This durability is due to the survival penalty yeast pay when they mutate to avoid making ethanol. In contrast, the production processes of high value chemicals are highly susceptible to mutations, which reduce yield and contribute to batch inconsistencies. Why is there this disparity between ethanol production and other more valuable molecules? Ethanol is a byproduct of catabolism, which is a process by which yeast break down feedstocks to produce energy. No energy synthesis means no survival.

To overcome the intrinsic challenge of producing anything other than ethanol, Amyris has been quietly building an innovative toolkit to increase strain stability. In this latest filing, they use genetic controls to reduce mutations that negatively affect yield. The proof is in the product, and in this case they showcase improvements to their key molecule, farnesene. The figure speaks for itself.

